Safety of pre-emptive donor lymphocyte infusions (DLI) based on mixed chimerism (MC) in peripheral blood or bone marrow subsets in children undergoing hematopoietic stem cell transplant (HSCT) for hematologic malignancies
Crossref DOI link: https://doi.org/10.1038/bmt.2017.45
Published Online: 2017-04-10
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liou, A
Wahlstrom, J T
Dvorak, C C
Horn, B N
Text and Data Mining valid from 2017-04-10
Version of Record valid from 2017-04-10
Article History
First Online: 10 April 2017
Competing interests
: The authors declare no conflict of interest.